Cited by 391Sirtuins and Resveratrol in MedicineNatural Antidiabetic Agents StudiesPhytochemicals and Antioxidant Activities

Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats

Open access
Rivera, Leonor, Morón, Rocío, Zarzuelo, Antonio, Galisteo, Milagros·2009·Biochemical Pharmacology

Abstract

Resveratrol is a natural polyphenolic stilbene derivative found in several human diet components that possess important and wide-ranging effects in biological systems including anticancer, anti-inflammatory, antioxidant, cardio-protective, and anti-ageing actions and beneficial properties against metabolic diseases. This study addresses the effects of long-term administration of resveratrol on several functional alterations arising from the metabolic syndrome experimental model of obese Zucker rats, and the possible mechanisms involved. The high plasma concentrations of triglycerides, total cholesterol, free fatty acids, insulin and leptin found in obese Zucker rats were reduced in obese rats that received resveratrol. Furthermore, the elevated hepatic lipid content was significantly lower in obese rats treated with resveratrol, an effect which was related to the increased phosphorylation of 5'-AMP-activated protein kinase (AMPK) and acetyl-CoA carboxylase (ACC) in the liver of these animals. Resveratrol treatment also improved the inflammatory status peculiar to this model, as it increased the concentration of adiponectin and lowered tumor necrosis factor-alpha production in the visceral adipose tissue (VAT) of obese Zucker rats. Moreover, chronic intake of resveratrol enhanced VAT eNOS expression among obese Zucker rats. These effects parallel the activation of AMPK and inhibition by phosphorylation of ACC in this tissue. The raised systolic blood pressure and reduced aortic eNOS expression found in obese Zucker rats were significantly improved in the resveratrol-treated obese rats. In conclusion, resveratrol improved dyslipidemia, hyperinsulinemia, hyperleptinemia and hypertension in obese Zucker rats, and produced anti-inflammatory effects in VAT, effects that seem to be mediated by AMPK activation.

Integrity signals

Registry

Crossref · 10.1016/j.bcp.2008.11.027

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rivera, L., Morón, R., Zarzuelo, A., & Galisteo, M.
Affiliations
Universidad de Granada (ES)
Corresponding author
Galisteo, Milagros
Venue
Biochemical Pharmacology
Publisher
Elsevier BV
Published
2009-03
Volume
77
Issue
6
Pages
1053-1063
ISSN
0006-2952 (ISSN-L)
OpenAlex
W2035006578
Cited by
391
References
52
Citations by year
2026: 2 · 2025: 7 · 2024: 8 · 2023: 5 · 2022: 5 · 2021: 12 · 2020: 20 · 2019: 19 · 2018: 23 · 2017: 22 · 2016: 31 · 2015: 39 · 2014: 36 · 2013: 57 · 2012: 30
FWCI
10.29
Type
journal article
Language
en
Open access
Locations
  • Biochemical Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
  • Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
  • Health Sciences › Medicine › Biochemistry › Phytochemicals and Antioxidant Activities
Keywords
resveratrol, metabolic syndrome, obesity, Zucker rats, hypertension, dyslipidemia, hyperinsulinemia, hyperleptinemia, hepatic lipid accumulation, AMPK, acetyl-CoA carboxylase, adiponectin, TNF-α, visceral adipose tissue inflammation, endothelial nitric oxide synthase, anti-inflammatory activity
MeSH terms
Resveratrol, Adipose Tissue, Animals, Blood Pressure, Disease Models, Animal, Drug Administration Schedule, Humans, Hypertension, Male, Obesity, Random Allocation, Rats, Zucker, Stilbenes, Metabolic Syndrome, Lipid Metabolism, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review